In this episode, the roles are reversed, with Heather asking Joe questions about his experiences with GLP-1 drugs. These include semaglutide and tirzepatide, or their brand names like Ozempic and Zepbound. Joe talks about his own experiences with being fat and using these drugs to become less fat. Then Heather fills us in on the possible economic ramifications of the growing use of GLP-1's.

Joe is using the show notes to promote the new Substack of his friend John, who recently retired from the US Capitol Police. Check out https://substack.com/@intentionalcommand for John's thoughts about topics like leadership and crisis management.

Don't forget to check out Heather's Substack as well: https://economyheather.substack.com/